Veterinary World


ISSN (Online): 2231-0916


 Editorial board

 Instructions for authors

 Reviewer guideline

 Open access policy





Open Access

Copyright: The authors. This article is an open access article licensed under the terms of the Creative Commons Attribution License ( which permits unrestricted use, distribution and reproduction in any medium, provided the work is properly cited.

Research (Published online : 12-07-2013)
7. Biochemical, histopathological and ultra structural profile after pulsed water medication of enrofloxacin in broiler chickens - Veerapandian Sureshkumar, Ghadevaru Sarathchandra and Jayaramachandran Ramesh

Vet World. 2013; 6(9): 668-673

Aim: A pharmacological study was undertaken to evaluate the safety and adverse effects of enrofloxacin administration in broiler chickens by assessing the serum biochemical parameters, associated histopathological and ultra structural changes in liver and kidney.

Materials and Methods: Birds in the treatment group were administered with enrofloxacin at the recommended therapeutic dose 10mg/kg body weight via drinking water for five successive days, while the control group (untreated group) received non medicated water. Serum biochemical parameters viz., total protein, albumin, lactate dehydrogenase, alkaline phosphatase, creatine kinase, lipase, triglyceride, gamma glutamyl transferase, urea, uric acid and creatinine were estimated at 24hour and 48hour intervals during the dosing and withdrawal periods, respectively. Liver and kidney tissue samples collected from 1, 3, 5, 7, and 9 days post treatment groups were subjected to histopathological and ultrastructural examinations.

Results: There was no significant change (p>0.05) in total protein, albumin, lactate dehydrogenase, alkaline phosphatase, creatine kinase, lipase, triglyceride and urea levels in the enrofloxacin administered broiler chickens at all the time points evaluated. However, a significant increase (p<0.05) in gamma glutamyl transferase, uric acid and creatinine levels were observed after the 4th dose of the enrofloxacin and on day 1 post treatment. During the withdrawal period, the elevated levels declined gradually and showed the trend towards control values as evidenced by a statistically insignificant difference on 3, 5, 7 and 9 days post treatment when compared to that of control group. These biochemical changes were substantiated by histopathological and ultrastructural changes elicited in liver and kidney.

Conclusion: The reversible trend observed in serum biochemical parameters, histopathological and ultra structural alterations in liver and kidney during the withdrawal period suggests that enrofloxacin is safe if administered to broiler chickens at the recommended therapeutic dose and if the stipulated withdrawal period is strictly adhered to.

Keywords: biochemical parameters, broiler chickens, enrofloxacin, histopathology, ultrastructural, veterinary pharmacovigilance


1. Johnston, A.M. (1998) Use of antimicrobial drugs in veterinarypractice. Br. Med. J. 317: 665-667.
PMid:9728002 PMCid:PMC1113841
2. Prescott, J.F., Baggot, J.D. and Walker, R.D. (2000) Fluoroquinolones, In: Prescott, J.F.,Baggot, J.D. and Walker, R.D., editors, Antimicrobial Therapy in Veterinary Medicine, 3rd edition. Ames: Iowa State University Press. 315-339.
3. Martinez, M., McDermontt, P. and Walker, R. (2006) Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals. Vet. J. 172: 10-28.
4. Papich, M.G. and Riviere, J.E. (2009) Fluoroquinolone antibacterialdrugs. In: Riviere, J.E. and Papich, M.G., editors, Veterinary Pharmacology and Therapeutics. 9th edition. Wiley-Blackwell, Iowa State University Press, USA. 983-1011.
5. Anderson, A.D., Nelson, J.M., Rossiter, S. and Angulo, F.J. (2003) Public health consequences of use of antimicrobial agents in food animals in the United States. Microb Drug Resist. 9: 373-379.
6. Wagman, A.S. and Wentland, M.P. (2007) Quinolone antibacterial agents. Comprehensive Medicinal Chemistry II, Chapter 7, 567-596.
7. Taccetti, G., Campana, S., Neri, A., Boni, V. and Festini, F. (2008) Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis. J. Chemother. 20: 166-169.
8. Kordick, D., Papich, M. and Breitschwerdt, E. (1997) Efficacy of enrofloxacin or doxycycline for treatment of Bartonella henselae or Bartonella clarridgeiae infection in cats. Antimicrob Agents Chemother. 41: 2448-2455.
PMid:9371348 PMCid:PMC164143
9. Todorov, T. (2004) A preclinical study on Biofloxavet C (enrofloxacin) tolerance in cats. Bulg J Vet Med. 7: 239-244.
10. Shoorijeh, S.J., Tamadon, A., Vahedi, M. and Behzadi, M.A. (2012) Hematological and biochemical alterations due to over dosage of enrofloxacin in cats. Pak Vet J. 32: 73-76.
11. Hooper, D.C. and Wolfson, J.S. (1985) The fluoroquino- lones: pharmacology, clinical uses, and toxicities in human. Antimicrob. Agents Chemother. 28: 716-721.
PMid:2936302 PMCid:PMC176369
12. Sureshkumar, V., Sarathchandra, G., Ramesh, J., Vairamuthu, S., Thejomoorthy, P. and Hariharan, P. (2012) The effect of enrofloxacin administration on haematological profile in broiler chicken – A safety pharmacology study. The Indian Journal of Field Veterinarians. 8: 20-24.
13. Sureshkumar, V., Saratchandra, G. and Ramesh, J. (2013) Effect of enrofloxacin on Zootechnical performance, behaviour and immunohistopathological response in broiler chicken. Veterinary World. 6:337-342
14. Patel, J.H., Varia, R.D., Patel, U.D. and Vihol, P.D. (2009) Safety level of levofloxacin following repeated oral adminis- tration in White Leghorn layer birds. Vet. World. 2: 137-139.
15. Knoll, U., Glunder, G. and Kietzmann, M. (1999) Comparative study of the plasma pharmacokinetics and tissue concentrations of danofloxacin and enrofloxacin in broiler chickens. J. Vet. Pharmacol. Therap., 22: 239-246.
16. Charleston, B., Gate, J.J., Aitken, I.A., Stephan, B. and Froyman, R. (1998) Comparison of the efficacies of three fluoroquinolone antimicrobial agents, given as continuous or pulsed-water medication, against Escherichia coli infection in chickens. Antimicrob.Agents Chemother. 42:83-87.
PMid:9449265 PMCid:PMC105460
17. Snedecor, G.W. and Cochran, W.G. (1994) Statistical methods, 8th Edn., Ames: Iowa State University Press.
18. Bancroft, J.D. and Gamble. M. (2008) Theory and practice of histological techniques. 6th edition. Churchill Livingstone, Philadelphia.
19. Elkholy, H.M., Elkomy, A.A., Awidat, S.K. and Elmajdoub, A.A. (2009) Tissue and egg residues and adverse effect of two oral enrofloxacin preparations; BaytrilŪ and EnrotrylŪ. Global Veterinaria, 3: 363-368.
20. Moustafa, A., Baset Abdel, I., El Mashad, A. and Tantawy, A. (1998) Pathological studies on enrofloxacin and its residues in broiler's chickens. Egypt. J. Comp. Pathol. Clin. Pathol. 11: 57-66.
21. Tras, B., Maden, M., Bas, A.L., Elmas, M., Yazar, E. and Civelek, T. (2001) Investigation of biochemical and haematological side-effects of enrofloxacin in dogs. J. Vet Med A. 48: 59-63.
22. Davoren, P. and Mainstone, K. (1993) Norfloxacin-induced hepatitis. Med J Aust.159: 423-424.
23. Jones, S.E. and Smith, R.H. (1997) Quinolones may induce hepatitis. Br Med J. 314: 869-870.
PMid:9093098 PMCid:PMC2126221
24. Ellakany, H.F., Abu El-Azm, I.M., Bekhit, A.A. and Shehawy, M.M. (2007) Studies on the effects of enrofloxacin overdose on different health parameters in broiler chickens BS. Vet. Med. J. 5th Scientific Conference, 176-186.
25. Shawky, M.A., Abdel-Baset, I., El-Mashad and Tantawy, A.A. (1998) Pathological studies on enrofloxacin and its residues in broiler chickens. Egypt. J. Comp. Pathol. Clin. Pathol. 11: 57-66.
26. Vaccaro, E., Giorgi, M., Longo, V., Mengozzi, G. and Cervasi, P.G. (2003) Inhibition of cytochrome P450 enzymes by enrofloxacin in the sea bass (Dicentrarchus labrax). Aquat. Toxicol.62: 27-33.
27. El Daly, A.A.A. (2011) The protective effect of green tea extract against enrofloxacin action on the rat liver; histological, histochemical and ultrastructural studies. J. Am. Sci. 7: 669- 679.